Clinical Trial Update: Behavioral Drug and HIV Risk Reduction Counseling in Methadone Patients in China [Phase 3]

View source ↗

Summary

Phase 3 trial update on a behavioral drug and HIV risk reduction counseling for methadone patients in China.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Opiate Dependence

Snippet

Sponsor: Yale University | Conditions: Opiate Dependence, HIV Infections | Phase 3 | Status: COMPLETED